Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
17:38
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

51st ERA-EDTA CONGRESS

 

31 May - 3 June 2014 AMSTERDAM
FAQs
   
Discussion forum - 51st ERA-EDTA CONGRESS
    Topic - H) Clinical Nephrology, Chronic Kidney Disease (CKD). H4) Bone disease in CKD 1-5.

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
SERUM OSTEOPROTEGERIN IS A PREDICTOR OF DIASTOLIC DYSFUNCTION AND VASCULAR STIFFNESS IN CHRONIC KIDNEY DISEASE PATIENTS  Rusu Elena 1      5/20/2014 9:58:00 PM  
INTER-METHOD VARIABILITY IN BONE ALKALINE PHOSPHATASE MEASUREMENT: CLINICAL IMPACT ON THE MANAGEMENT OF DIALYSIS PATIENTS  Pierre Delanaye 1      5/20/2014 12:54:00 PM  
SCLEROSTIN CONCENTRATION IS NOT PREDICTIVE OF MORTALITY IN HEMODIALYSIS PATIENTS  Pierre Delanaye 1      5/20/2014 12:51:00 PM  
INFLAMMATION MAY INDUCE AN OSTEOCLASTOGENIC PHENOTYPE IN PERIPHERAL MONONUCLEAR CELLS (PBMC) OF CHRONIC KIDNEY DISEASE (CKD) PATIENTS  Margherita Gigante 1      5/20/2014 10:06:00 AM  
FIBROBLAST GROWTH FACTOR 23 CORRELATES WITH AORTIC VALVE CALCIFICATIONS AND NON-DIPPER STATUS IN CHRONIC KIDNEY DISEASE PATIENTS  Diana-Silvia Zilisteanu 1      5/19/2014 1:41:00 PM  
HIGHER SERUM PHOSPHORUS LEVELS AT THE INITIAL VISIT PREDICT PREDICT MORE RAPID DECLINE IN PRE-DIALYSIS CKD PATIENTS IN JAPAN  Tomoki Kawasaki 1      5/19/2014 12:01:00 PM  
HYPOVITAMINOSIS D IN NONDIALYZED CHRONIC KIDNEY DISEASE PATIENTS: A CROSS SECTION STUDY  RODRIGO AMBLARD WANDERLEY 1      5/19/2014 2:20:00 AM  
ASSOCIATION BETWEEN ALKALINE PHOSPHATASE AND TOTAL BONE MINERAL DENSITY IN CKD STAGE 5 PATIENTS  Tony Qureshi 1      5/16/2014 8:23:00 PM  
EFFECTS OF INFLAMMATION ON SERUM LEVELS OF SCLEROSTIN (SOST) IN HEMODIALYSIS (HD) PATIENTS  lida tartaglione 1      5/16/2014 10:43:00 AM  
EFFECTS OF PREOPERATIVE CINACALCET HYDROCHLORIDE (CH) TREATMENT ON OPERATIVE COUSE OF PARATHYROIDECTOMY (PTX) AND PATHOLOGICAL CHANGES OF RESECTED PARATHYROID GLANDS (PTGS).  Akiko Takeshima 1      5/16/2014 9:12:00 AM  
PARATHYROIDECTOMY IMPROVES RESTLESS LEG SYNDROME IN PATIENTS UNDER HEMODIALYSIS  Roberto Santos 1      5/14/2014 3:49:00 AM  
FGF23 IMPAIRS MICROVASCULAR FUNCTION AND MYOCARDIAL PERFUSION IN EXPERIMENTAL RENAL FAILURE  Melissa Verkaik 1      5/13/2014 1:00:00 PM  
STUDY OF FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE STAGE II TO IV  Kalpesh Gohel 1      5/7/2014 2:24:00 PM  
OSTEONECTIN (SPARC) EXPRESSION IN VASCULAR CALCIFICATION: IN VITRO AND EX VIVO STUDIES  mario cozzolino 1      5/6/2014 2:17:00 PM  
CURRENT MANAGEMENT ON CKD MBD IN WALES NOT SO NICE ?  FARID GHALLI 1      5/5/2014 10:45:00 PM  
IMPACT OF DIFFERENT TREATMENTS OF SECONDARY HYPERPARATHYROIDISM (PARACALCITOL,ALFACALCIDOL,CINACALCET LOW-DOSE ALFACALCIDOL, CINACALCET PARACALCITOL) ON FGF-23, TESTOTERONE, PTH, CA AND P IN DIALYSIS PATIENTS.  Evgeny Shutov 1      5/2/2014 12:11:00 PM  
       




Most viewed poster for this congress
Poster: 7
Visits: 477
Title: SEVERE SYMPTOMATIC ACUTE HYPONATREMIA IN TRAUMATIC BRAIN INJURY RESPONDS VERY RAPIDLY SINGLE 15 MG DOSE OF TOLVAPTAN: A MAYO CLINIC HEALTH SYSTEM HOSPITAL EXPERIENCE - NEED FOR CAUTION WITH TOLVAPTAN IN YOUNGER PATIENTS WITH PRESERVED RENAL FUNCTION
Authors: MACAULAY ONUIGBO ,
Centre: MAYO CLINIC, ROCHESTER & MAYO CLINIC HEALTH SYSTEM, EAU CLAIRE

Poster most viewed in this topic
Poster: 545
Visits: 87
Title: IMPACT OF DIFFERENT TREATMENTS OF SECONDARY HYPERPARATHYROIDISM (PARACALCITOL,ALFACALCIDOL,CINACALCET LOW-DOSE ALFACALCIDOL, CINACALCET PARACALCITOL) ON FGF-23, TESTOTERONE, PTH, CA AND P IN DIALYSIS PATIENTS.
Authors: Evgeny Shutov ,
Centre: City hosital named after S.P.Botkin


 








PosterSessionOnline
Logo Draft
 
Logo Cert